Cargando…
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489819/ https://www.ncbi.nlm.nih.gov/pubmed/26170615 http://dx.doi.org/10.2147/BTT.S87768 |
_version_ | 1782379425227079680 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4489819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44898192015-07-13 New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] Biologics Corrigendum Dove Medical Press 2015-06-29 /pmc/articles/PMC4489819/ /pubmed/26170615 http://dx.doi.org/10.2147/BTT.S87768 Text en © 2015 Frati et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Corrigendum New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
title | New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
title_full | New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
title_fullStr | New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
title_full_unstemmed | New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
title_short | New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] |
title_sort | new product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [corrigendum] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489819/ https://www.ncbi.nlm.nih.gov/pubmed/26170615 http://dx.doi.org/10.2147/BTT.S87768 |